WaveMan · Form 4
Chan Phillip P. insider trades
> Search tickers & screens ⌘K
LIVE

Chan Phillip P. insider trades

Chan Phillip P. has filed 20 Form 4s with the SEC that we hold, all for Cytosorbents Corp (CTSO), as Chief Executive Officer, Director. Across all of them we count 15 purchases worth $520.7K and 0 sales worth $0 reported on Form 4. In the last 12 months: 4 purchases ($197.5K) and 0 sales ($0). The largest single trade was a purchase of 251,136 shares of Cytosorbents Corp worth $100.5K, dated 2026-06-12. The first filing on our record is dated 2021-12-13 and the latest 2026-09-16.

Cytosorbents Corp (CTSO)

Chief Executive Officer, Director · 20 filings · 15 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-12-10P, purchase reported on Form 45,000$26.2K2021-12-13
2021-12-29P, purchase reported on Form 4100$4042022-01-03
2021-12-29P, purchase reported on Form 49,438$38.2K2022-01-03
2021-12-30P, purchase reported on Form 45,462$22.1K2022-01-03
2022-06-09P, purchase reported on Form 416,000$34.7K2022-06-10
2022-06-16P, purchase reported on Form 42,221$4.1K2022-06-21
2022-09-08P, purchase reported on Form 435,000$59.5K2022-09-12
2022-12-06P, purchase reported on Form 414,291$18.0K2022-12-08
2022-12-07P, purchase reported on Form 49,850$12.4K2022-12-08
2022-12-08P, purchase reported on Form 45,859$7.4K2022-12-09
2023-12-13P, purchase reported on Form 475,188$100.0K2023-12-15
2026-06-12P, purchase reported on Form 4251,136$100.5K2026-06-15
2026-06-15P, purchase reported on Form 410,333$4.4K2026-06-15
2026-09-04P, purchase reported on Form 4200,000$70.0K2026-09-09
2026-09-15P, purchase reported on Form 43,774$22.6K2026-09-16
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1442786) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms